Krystal Biotech, Inc. KRYS Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s change in other assets?
- Krystal Biotech, Inc. (KRYS) reported change in other assets of $1.7M in Q1 2026.
- How has Krystal Biotech, Inc.'s change in other assets changed year-over-year?
- Krystal Biotech, Inc.'s change in other assets decreased by 50.5% year-over-year, from $3.43M to $1.7M.
- What is the long-term trend for Krystal Biotech, Inc.'s change in other assets?
- Over 2 years (2021 to 2023), Krystal Biotech, Inc.'s change in other assets has grown at a -0.8% compound annual growth rate (CAGR), from -$65K to $64K.
- What does change in other assets mean?
- The net change in miscellaneous short-term assets not classified elsewhere.
- How do you interpret change in other assets?
- Significant fluctuations may indicate changes in corporate strategy, such as increased deposits for facilities or changes in deferred expense recognition.
- How does change in other assets compare across companies?
- Varies widely by company size and complexity of operations.